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Abstract: Two new sesquiterpenes, 1β,5α,6α,14-tetraacetoxy-9α-benzoyloxy-7β 
H-eudesman-2β,11-diol (1) and 4α,5α-diacetoxy-9α-benzoyloxy-7βH-eudesman-1β,2β,11, 
14-tetraol (2), were produced as stress metabolites in the cultured mycelia of Pestalotiopsis sp. 
Z233 isolated from the algae Sargassum horneri in response to abiotic stress elicitation by 
CuCl2. Their structures were established by spectroscopic means. New compounds 1 and 2 
showed tyrosinase inhibitory activities with IC50 value of 14.8 µM and 22.3 µM. 
Keywords: sesquiterpenes; Pestalotiopsis sp.; abiotic stress; tyrosinase inhibitory activities 
 
1. Introduction 
Marine-derived fungi, living in a stressful habitat, are of great interest as new promising sources of 
biologically active products. Since marine organisms live in a biologically competitive environment 
with unique conditions of pH, temperature, pressure, oxygen, light, nutrients and salinity, the chemical 
diversity of the secondary metabolites from marine fungi is considerably high [1–6]. New strategies of 
discovery of novel bioactive compounds including biotic [7–9] and abiotic [10] stress elicitations have 
been applied. Fungi of the genus Pestalotiopsis are characterized by their extensive distribution and 
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wide genetic, biological and chemical diversity [11]. Natural products from the Pestalotiopsis species 
exhibit considerable chemical diversity and various bioactivities [11–16]. In this study, two novel 
sesquiterpenes were produced as stress metabolites in the cultured mycelia of Pestalotiopsis sp. Z233 
isolated from algae Sargassum horneri in response to abiotic stress elicitation by CuCl2. 
Tyrosinase is a multifunctional copper-containing enzyme, which catalyzes the hydroxylation  
of L-tyrosine to 3,4-dihydroxyphenylalanine (L-DOPA) and the subsequent oxidation of L-DOPA to 
dopaquinone, is widely distributed in microorganisms, animals and plants [17]. Tyrosinase inhibitors 
can be clinically useful for the treatment of some dermatological disorders associated with melanin 
hyperpigmentation [18]. Several tyrosinase inhibitors have been studied in our previous studies [19].  
In continuation of our search for bioactive natural products that can be used for the treatment of 
dermatological disorders associated with melanin hyperpigmentation, stress metabolites in the cultured 
mycelia of Pestalotiopsis sp. Z233 were investigated. 
2. Results and Discussion 
The Pestalotiopsis sp. Z233, isolated from algae Sargassum horneri, was grown in the absence and, 
in parallel experiment, in the presence of the abiotic stress agent, CuCl2. Upon comparison of TLC 
plates of mycelial extracts from both conditions, two additional spots in the extract of CuCl2  
treated culture were found. These two new compounds were presumably produced in response to 
abiotic stress. They were isolated by preparative TLC, and purified by Sephadex LH-20  
column chromatography. 
Compound 1 was obtained as a yellowish oil. The HR-TOF-MS exhibited an ion peak at m/z 
593.2595 [M + H]
+
 (calcd. for C30H41O12, 593.2593), corresponding to the molecular formula, 
C30H40O12. The 
13
C NMR spectrum showed the presence of eight signals for four acetoxyl moieties, 
seven signals for a benzoyloxyl moiety, with the remaining 15 resonances corresponding to a 
sesquiterpene skeleton. The 
1
H and 
13
C NMR spectra indicated compound 1 to be a highly oxygenated 
eudesmane derivative (Table 1). The 15 signals for the eudesmane backbone comprised three methyls 
(δC 25.5, 30.1 and 17.3), one oxymethylene (δC 64.4), two methylenes (δC 30.3 and 34.2), two 
methines (δC 32.5 and 47.9), four oxymethines (δC 70.9, 68.5, 76.9 and 68.8), a quaternary carbon  
(δC 52.7), two oxygenated quaternary carbons (δC 88.8 and 82.4). Two of the three methyls (δC 25.5 
and 30.1) were assigned to an oxygenated isopropyl group (carbinol signal at δC 82.4), with the third 
(δC 17.3) being Me-15. In the COSY spectrum of 1 (Figure 1), the oxymethine proton at δH 5.38  
(m, H-2) was coupled with the oxymethine proton at δH 5.50 (d, J = 3.5 Hz, H-1) and methylene 
protons at δH 1.75 (dd, 14.5, 2.0 Hz, H-3a) and 2.13 (dd, 14.5, 3.2 Hz, H-3b). The methine proton at δH 
2.22 (m, H-4) exhibited cross peaks with methylene protons of H2-3 and methyl protons at δH 1.12  
(d, J = 7.5 Hz, Me-15) in the COSY spectrum of 1. A sequence of H-1/H-2/H-3/H-4/Me-15 was 
deduced from above 
1
H 
1
H COSY analyses. Another sequence of H-6/H-7/H-8/H-9 was inferred from 
the observation of COSY cross peaks from the methine proton at δH 2.19 (m, H-7) to the oxymethine 
proton at δH 5.88 (d, J = 1.0 Hz, H-6) and methylene protons at δH 2.40 (m, H-8a) and 2.16 (m, H-8b), 
and cross peaks from H2-8 to the oxymethine proton at δH 5.34 (m, H-9). The benzoyloxyl moiety was 
assigned at C-9 from the observation of HMBC correlations from the oxymethine proton at δH 5.34  
(m, H-9) and aromatic protons at δH 7.90 (dd, J = 8.0, 2.0 Hz) to the benzylic ester carbon resonance at 
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δC 164.4 (s, C-16) and the oxygenated methylene carbon resonance at δC 64.4 (t, C-14). The HMBC 
peaks from two methyl groups at δH 1.41 (s, Me-12) and 1.42 (s, Me-13) to two oxygenated quaternary 
carbons at δC 88.8 (s, C-7) and 82.4 (s, C-11) positioned the oxygenated isopropyl group at C-7 of ring 
B. Three of four acetoxyls were assigned to C-1, C-6 and C-14 from analysis of the HMBC cross 
peaks of H-1/C-25, H-6/C-29 and H-14/C-23. The NOESY correlations from acetoxyl Me-28 to H-1 
and H-2 at ring A positioned the remaining acetoxyl group at oxygenated C-5. The relative 
configuration of 1 was determined from the analyses of NOESY data. The oxygenated H-9 showed 
NOESY correlations with H2-14, indicating that benzoyloxyl moiety was α-oriented. The H-6 and H-7 
protons at δH 5.88 (m) and 2.19 (m) showed NOESY correlations with the methylene protons at  
δH 5.00 and 4.25 (d, J = 12.7, H2-14), contributing an α-oriented acetoxyl unit and an α-oriented 
oxygenated isopropyl group in 1 as drawn. The NOESY cross peak of H2-14β/Me-15 implied a  
β-oriented CH3 at C-4. H-1 showed strong NOESY cross peak with aromatic H-18/22, revealing a  
β-oriented OH at C-1. The 3.5 Hz coupling constant between H-1 and H-2 indicated an equatorial H-2 
proton, assigning the hydroxyl group at C-2 as a β configuration. This inference was also confirmed by 
the observation of the NOESY correlation from the axial proton of H-3α to H-2α. Therefore, the 
structure of this isolate was elucidated as 1β,5α,6α,14-tetraacetoxy-9α-benzoyloxy-7βH-eudesman-2β, 
11-diol (Figure 2). The assignment of NMR signals of 1 is listed in Table 1.  
Table 1. NMR Data (500 MHz) for Compound 1 and 2 in DMSO-d6. 
Position 
1 2 
δC 
a,b
, mult. δH 
c
, mult. (J in Hz) δC 
a,b
, mult. δH 
c
, mult. (J in Hz) 
1 70.9, CH 5.50 d (3.5) 70.9, CH 5.50 d (3.5) 
2 68.5, CH 5,38, m 68.4, CH 5.36, m 
3a 30.3, CH2 1.75, dd (14.5, 2.0) 39.0, CH2 1.83 dd (14.0, 2.0) 
3b  2.13, dd (14.5, 3.2)  2.09, dd (14.0, 3.0) 
4 32.5, CH 2.22, m 68.8, C  
5 88.8, C  88.8, C  
6a 76.9, CH 5.88, d (1.0) 30.7, CH2 2.18, m 
6b    1.80, m 
7 47.9, CH 2.19, m 42.4, CH 2.06, m 
8a 34.2, CH2 2.40, m 32.2, CH2 2.16, m 
8b  2.16, m  2.02, m 
9 68.8, CH 5.34, m 68.8, CH 5.69, m 
10 52.7, C  50.9, CH  
11 82.4, C  83.1, C  
12 25.5, CH3 1.41, s 24.1, CH3 1.44, s 
13 30.1, CH3 1.42, s 29.1, CH3 1.29, s 
14a 64.4, CH2 5.00, d (12.7) 65.5, CH2 5.11, d (12.5) 
14b  4.25, d (12.7)  4.79, d (12.5) 
15 17.3, CH3 1.12, d (7.5) 26.0, CH3 1.37, s 
16 164.4, C  164.6, C  
17 128.8, C  128.7, C  
18/22 129.5, CH 7.90, dd (8.0, 2.0) 129.5, CH 7.93, dd (8.0, 2.0) 
19/21 128.5, CH 7.52, t (8.0) 128.5, CH 7.53, t (8.0) 
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Table 1. Cont. 
20 133.6, CH 7.65, t (8.0) 133.5, CH 7.64, t (8.0) 
23 169.9, C  168.3, C  
24 20.8, CH3 2.19, s 20.7, CH3 1.98, s 
25 168.6, C  169.3, C  
26 20.0, CH3 1.46, s 20.0, CH3 1.38, s 
27 169.4, C    
28 20.8 CH3 2.20, s   
29 169.6, C    
30 21.0, CH3 2.09, s   
a
 Recorded at 125 MHz; 
b
 Multiplicities inferred from DEPT and HMQC experiments; 
c
 Recorded at  
500 MHz. 
Figure 1. Key 
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Figure 2. Structures of compounds 1 and 2. 
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Compound 2 was obtained as a yellow gum. The HR-TOF-MS exhibited an ion peak at m/z 
509.2385 [M + H]
+
 (calcd. for C26H37O10, 509.2381), indicating that the molecular formula was 
C26H36O10 with nine degrees of unsaturation. The NMR data (Table 1) in the downfield region of 2 
were similar to those of the compound 1, 1β,5α,6α,14-tetraacetoxy-9α-benzoyloxy-7βH-eudesman-2β, 
11-diol, which was isolated from the same fungus. However, the deshielded oxymethine proton of H-6 
was absent in 2. In the upfield region of the NMR spectra of 2, two methylene protons at δH 2.18 and 
1.80 (2 m, H2-6) were added, whereas two methyl were absent (Table 1), when compared with those of 
compound 1. The doublet Me proton signal was downshifted to δH 1.37, and showed itself as a singlet 
in the upfield region of the NMR spectra of 2 as compared with that of compound 1. These differences 
suggested that C-4 was substituted in 2, and two acetoxyl groups were transformed to hydroxyl groups. 
No long range correlations were observed from oxymethine protons of H-1 and H-2, oxymethylene 
protons of H2-14 to any of the two acetoxyl ester carbonyl carbons, indicating that C-1, C-2 and C-14 
were hydroxylated. The oxygenated quaternary carbon at δC 68.8 (s) was attributed to C-4 from the 
observation of long range correlations from the oxymethine proton signal at δH 5.36 (m, H-2) and the 
singlet Me proton signal at δH 1.37 (s, Me-15) to the carbon signal at δC 68.8 (s) (Figure 1). NOESY 
correlations from two acetoxyl Me proton signals to H-1 and H-2 at ring A positioned two acetoxyls at 
C-4 and C-5. The oxygenated isopropyl group was assigned at C-7 from the analyses of HMBC cross 
peaks of Me-12/C-7, M-13/C-7 and H-9/C-7. C-7 was proved to be linked to oxygenated quaternary 
carbon C-5 via a methylene bridge from analysis of the HMBC cross peaks from H2-6 and H-7 to C-5. 
The relative configuration of 2 was deduced to be the same as in 1. The NOESY cross peak of  
Me-26/H-1α, Me-15β/H2-14β implied a trans eudesmane. The hydroxyl groups at C-1 and C-2 were  
β-oriented as shown by the observation of NOESY cross peaks of H-1α/H-3α and H-2α/H-3α  
in the NOESY experiment. H-7 and H-9 were proved to be β-oriented from the analyses of  
NOESY peaks of H2-14β/H-7β and H2-14β/H-9β. The new eudesmane derivative was elucidated as  
4α,5α-diacetoxy-9α-benzoyloxy-7βH-eudesman-1β,2β,11,14-tetraol. The assignment of NMR signals 
of 2 is listed in Table 1.  
Two new compounds were tested for tyrosinase inhibitory activities [19]. 1β,5α,6α,14-tetraacet 
oxy-9α-benzoyloxy-7βH-eudesman-2β,11-diol and 4α,5α-diaacetoxy-9α-benzoyloxy-7βH-eudesman-1β, 
2β,11,14-tetraol showed IC50 values of 14.8 µM and 22.3 µM, when the active compounds were 
compared to the standard tyrosinase inhibitor kojic acid (IC50 = 21.2 µM).  
3. Experimental Section  
3.1. General Experimental Procedures 
Optical rotations were recorded on a Perkin-Elmer-341 polarimeter. The IR spectra (CHCl3) were 
run on a NicoletAvatar-360FT-IR spectrometer. 
1
H NMR (500 MHz) and 
13
C NMR (125 MHz) spectra 
were measured at 25 °C on a Bruker AVANCE DMX 500 NMR spectrometer with TMS as internal 
standard. TOF-MS were recorded on a GCT-Premier GC-TOF-MS spectrometer. ESIMS were recorded 
on an Agilent 6460 Triple Quad LC/MS. TLC was performed using Merck precoated plates (Silica gel 
60 F254) of 0.25 mm thickness. Sephadex LH-20 (Amersham) was used for column chromatography. 
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3.2. Fungal Cultivation and Stress Applications  
The fungus Pestalotiopsis sp. Z233 was separated from the marine algae Sargassum horneri, which 
was collected from seashore in Wenzhou, China, and identified by its ITS-5.8s rDNA sequences. 
Subcultures of the organism are deposited at the Department of Ocean Science and Engineering, 
Zhejiang University. Cultures were separated into control (5 L) and stressed groups (5 L). The control 
fungus was grown in the culture medium consisting of (g·L
−1
) sucrose (66.0 g), yeast extract (10.0 g), 
silkworm chrysalis (30.0 g), MgSO4·7H2O (0.4 g), and KH2PO4 (0.4 g) in sterilized and filtrated 
natural seawater collected from Wenzhou, China. The stressed culture medium consisted of additional 
50 µmol/L CuCl2. The fermentations were carried out at 24 °C for 10 days.  
3.3. Extraction and Isolation 
The whole culture of the control and stressed broth of Pestalotiopsis sp. Z233 (5 L) were filtered. 
The air-dried mycelia of control (48.4 g) and the stressed group (45.4 g) were extracted at room 
temperature with MeOH (3 × 1 L), respectively. The extracts were evaporated in vacuo to afford a 
gummy residue for both Cu treated (2.2 g) and corresponding control (2.7 g). The residues were 
partitioned in H2O (500 mL) and extracted successively with EtOAc (3 × 500 mL) and n-butanol  
(3 × 500 mL). The EtOAc and n-butanol extracts of the treated and control cultures were subjected to 
TLC examination on aluminium sheets pre-coated with Silica gel 60 F 254 (Merck). The spots were 
applied in as equal amounts as possible. The plates were developed in the following developing 
solvent systems: benzene–acetone (6:1), benzene–EtOAc (5:1) petroleum ether–EtOAc (5:1) for the 
EtOAc extract; CHCl3–MeOH (3:1), CH2Cl2–MeOH (4:1) and benzene–CHCl3–MeOH (1:3:1) for the 
n-butanol extract. After development, the plates were examined under UV light (250 nm) to locate any 
additional spots in the different extracts of the treatments in comparison with those of the 
corresponding control extracts. The spots on the plates were also visualized by spraying with an  
EtOH–H2SO4 solution. Two additional compounds were detected on the plates developed in  
benzene–acetone (6:1) solvent system in the EtOAc extract of stress elicited mycelium. Several  
prep-TLC plates were prepared and the target compounds were isolated by preparative TLC in the 
developing solvent systems of benzene–acetone (6:1). The crude compounds were applied to a 
Sephadex LH-20 column (1 × 80 cm, 38 g, Amersham), and eluted with acetone to yield pure 
compounds 1 (8.4 mg) and 2 (7.0 mg). 
1β,5α,6α,14-Tetraacetoxy-9α-benzoyloxy-7βH-eudesman-2β,11-diol (1): yellowish oil; [α]24D −22  
(c 0.001, CHCl3); UV (MeOH) λmax (log є) 230 (4.11), 254 (4.23), 280 (4.56) nm; IR νmax 3422, 1766, 
1614, 1515, 1333, 1111, 721 cm
−1
; 
1
H NMR and 
13
C NMR, see Table 1; ESIMS m/z 593 [M + H]
+
;  
HR-TOF-MS m/z 593.2595 [M + H]
+
 (calcd. for C30H41O12, 593.2593).  
4α,5α-Diacetoxy-9α-benzoyloxy-7βH-eudesman-1β,2β,11,14-tetraol (3): yellow gum; [α]24D −26  
(c 0.001, CHCl3); UV (MeOH) λmax (log є) 230 (4.30), 254 (4.17), 280 (4.43) nm; IR νmax 3416, 1766, 
1615, 1513, 1324, 1113, 824 cm
−1
; 
1
H NMR and 
13
C NMR, see Table 1; ESIMS m/z 509 [M + H]
+
;  
HR-TOF-MS m/z 509.2385 [M + H]
+
 (calcd. for C26H37O10, 509.2381).  
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3.4. Tyrosinase Inhibition Assay 
Tyrosinase inhibition assay were performed in 96-well microplate format using SpectraMax 340 
microplate reader according to the previously developed method [19]. The compounds were initially 
screened for the O-diphenolase inhibitory activity of tyrosinase using L-DOPA as substrate. All active 
inhibitors from the preliminary screening were subjected to IC50 studies. Compounds were dissolved in 
methanol to a concentration of 2.5%. Mushroom tyrosinase (28 nM) were preincubated with the 
compounds in 50 nM Na-phosphate buffer (pH 6.8) for 10 min at 25 °C. Then the L-DOPA (0.5 mM) 
was added to the reaction mixture and the enzyme reaction was monitored by measuring the change in 
absorbance at 475 nm (at 37 °C) due to the formation of the DOPAchrome for 10 min. The percent 
inhibition of the enzyme was calculated as follows: 
Percent inhibition (%) = [(B − S)/B] × 100 
The B and S are the absorbance for the blank and samples, respectively. After screening of the 
compounds, median inhibitory concentration (IC50) was calculated. Kojic acid was used as standard 
inhibitors for the tyrosinase.  
4. Conclusions 
In this study, two novel sesquiterpenes were produced as stress metabolites by the mycelia of 
cultured Pestalotiopsis sp. Z233 in response to abiotic stress elicitation by CuCl2. These new 
metabolites possess interesting eudesmane skeleton, and exhibited potent tyrosinase inhibitory 
activities, indicating that metal stress elicitation on marine fungi was a promising strategy to discover 
new bioactive natural compounds. 
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